|
Clinicopathological feature
|
Case
|
miR-29b expression
|
p
|
EVT4 expression
|
p
|
|---|
|
Age (years)
| | | | | |
|
< 60
|
35
|
0.56 ± 0.15
|
0.476
|
2.40 ± 0.31
|
0.493
|
|
≥ 60
|
41
|
0.54 ± 0.09
|
2.44 ± 0.19
|
|
Gender
| | | | | |
|
Male
|
54
|
0.55 ± 0.12
|
0.999
|
2.42 ± 0.26
|
0.877
|
|
Female
|
22
|
0.55 ± 0.11
|
2.43 ± 0.24
|
|
Tumor location
| | | | | |
|
Colon
|
29
|
0.57 ± 0.10
|
0.310
|
2.39 ± 0.22
|
0.404
|
|
Rectum
|
47
|
0.54 ± 0.13
|
2.44 ± 0.27
|
|
Tumor size (cm)
| | | | | |
|
< 5
|
41
|
0.53 ± 0.09
|
0.137
|
2.45 ± 0.20
|
0.302
|
|
≥ 5
|
35
|
0.57 ± 0.14
|
2.39 ± 0.30
|
|
Differentiation grade
| | | | | |
|
Well/moderate
|
49
|
0.62 ± 0.09
|
< 0.001
|
2.28 ± 0.17
|
< 0.001
|
|
Poor
|
27
|
0.42 ± 0.05
|
2.68 ± 0.12
|
|
LNM
| | | | | |
|
No
|
40
|
0.65 ± 0.07
|
< 0.001
|
2.23 ± 0.16
|
< 0.001
|
|
Yes
|
36
|
0.44 ± 0.06
|
2.63 ± 0.13
|
|
TNM staging
| | | | | |
|
I/II
|
33
|
0.67 ± 0.06
|
< 0.001
|
2.19 ± 0.14
|
< 0.001
|
|
III/IV
|
43
|
0.46 ± 0.07
|
2.60 ± 0.14
|
- CRC, colorectal cancer; miR-29b, microRNA-29b; ETV4, ETS variant 4; LNM, lymph node metastasis; TNM, tumor node metastasis
